Saturday, March 2, 2024

CATEGORY

AstraZeneca

Lung Cancer Chemotherapy Treatment Tagrisso Plus Receives US FDA Approval

AstraZeneca's groundbreaking development in lung cancer treatment, Tagrisso, coupled with chemotherapy, has received FDA approval for adult patients with locally advanced or metastatic epidermal...

Priority Review Granted in the US for Enhertu in Metastatic HER2-Positive Solid Tumors

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for...

Encourage AstraZeneca’s Vaccine Facility Expansion by UK Government Financial Aid Package

The UK government is contemplating a significant financial aid package to incentivize AstraZeneca (AZ) to expand its vaccine facility in Speke, near Liverpool. According...

Paroxysmal Nocturnal Hemoglobinuria Treatment Danicopan First Approval Received in Japan

AstraZeneca (AZ) has achieved a significant milestone with the first global regulatory approval for Voydeya, an oral Factor D inhibitor, in Japan, representing a...

Beyfortus Receives Approval in China for Infant Respiratory Syncytial Virus Disease Prevention

AstraZeneca and Sanofi's nirsevimab, commercially known as Beyfortus, has gained approval in China for averting lower respiratory tract infections (LRTIs) caused by respiratory syncytial...

Wainua Gets First US Approval for Hereditary Transthyretin-Mediated Amyloidosis

The recent approval of Wainua (eplontersen) by the US Food and Drug Administration (FDA) for the treatment of hereditary transthyretin-mediated amyloidosis (ATTRv-PN) signifies a...

Advancing Hematology Science: AstraZeneca’s Presence at ASH 2023

AstraZeneca, in conjunction with Alexion, will unveil a breadth of data spanning 63 abstracts at the 65th American Society of Hematology (ASH) Annual Meeting...

AstraZeneca Launches Evinova Digital Health Solution

AstraZeneca has introduced Evinova, a groundbreaking digital health solutions provider aimed at revolutionizing the healthcare industry. With significant support from AstraZeneca and strategic partnerships...

AstraZeneca Re-enters Obesity Drug Market with $185 Million Acquisition

AstraZeneca, a global pharmaceutical giant, has purchased Eccogene's ECC5004, a promising obesity drug, for $185 million. The deal also includes the potential for an...

AstraZeneca’s Imfinzi Receives Approval in China for Groundbreaking Biliary Tract Cancer Treatment

AstraZeneca has achieved a significant milestone in cancer treatment with the approval of its drug Imfinzi (durvalumab) in China for the 1st-line treatment of...

Latest news

Sticky Image